Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec Signs Distribution Pact with Funakoshi

NEW YORK (GenomeWeb News) —Caprotec Bioanalytics has tapped Funakoshi to market and sell its research products in Japan, the Berlin-based company said today.

Under an exclusive agreement, Funakoshi will distribute Caprotec products based on its Capture Compound Mass Spectrometry technology. The CCMS technology consists of small, tri-functional molecules that are used to isolate proteins from biological samples, which are then identified and characterized by mass spectrometry.

"To establish a distribution channel for our products into the Japanese market is of strategic importance to us," Caprotec Bioanalytics CEO Hubert Köster said in a statement.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.